Abstract
Introduction
Tm:YAG 2 μm cw laser prostatectomy was introduced in the treatment of benign ptostatic obstruction (BPO). Since then numerous studies have been published proving efficacy during follow-up. However, different surgical techniques were introduced with different names for similar techniques that complicate comparison. This reviews aim was to compare published data and break down surgical techniques to core points. The authors define validate appellations for different surgical techniques and propose further use of these names to ensure homogenous nomenclature.
Materials and methods
All publications on Thulium:YAG prostatectomy have been included in this review. Articles were reviewed and associated due to the nature of the surgical approach. A systematic review of published data was performed.
Results
Sixteen peer-reviewed publications dealing with Tm:YAG laser prostatectomy were printed since 2005. Four different surgical principles are described, including vaporization, resection and enucleation. Follow-up, up to 24 months, showed durable functional results.
Conclusion
Efficacy of Tm:YAG prostatectomy was shown. Surgical techniques include “Tm:YAG Vaporization of the prostate (ThuVAP)”, “Tm:YAG VapoResection of the prostate (ThuVaRP)” and “Tm:YAG VapoEnucleation of the prostate (ThuVEP)”. The almost blunt enucleation is introduced as “Tm:YAG laser enucleation of the prostate (ThuLEP)”. The authors recommend the use of this neologism in the future. Further, large-scale prospective studies are needed to prove long-term durability. To initiate and canalize these upcoming studies, the Urothulium Study Group© was founded, combining international experts on Thulium:YAG laser prostatectomy under its roof.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Xia SJ, Zhang YN, Lu J, Sun XW, Zhang J, Zhu YV, Li WG (2005) Thulium laser resection of prostate-tangerine technique in the treatment of benign prostatic hyperplasia. Zhonghua Yi Xue Za Zhi 85:3225–3228
Bach T, Herrmann TRW, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a one-year follow-up. World J Urol 25:257–262
Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. AJA 11:277–281
Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28:45–51
Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Haecker A (2008) Systemic evaluation of recently introduced 2-μm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22:1041–1045
Bach T, Huck N, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs. 120 W thulium:yttrium-aluminium-garnet 2 μm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systemic ex-vivo evaluation. BJU Int (Nov 13 [Epub ahead of print])
Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2008) Vaporesection for managing benign prostatic hyperplasia using a 2-μm continuous—wave laser: a prospective trial with 1-year follow-up. BJU Int 103:352–356
Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382–389
Mattioli S, Munoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, Teichmann H (2008) Treatment of benign prostatic hypertrophy with the Revolix laser. Arch Esp Urol 61:1037–1043
Szlauer R, Götschl R, Razmaria A, Paras L, Schmeller NT (2009) Endoscopic vaporesection of the prostate using the continuous-wave 2-μm thulium laser: outcome and demonstration of the surgical technique. Eur Urol 55:368–375
Shao Q, Zhang FB, Shang DH, Tian Y (2009) Comparison of holmium and thulium laser in transurethral enucleation of the prostate. Zhonghua Nan Ke Xue 15:346–349
Bach T, Herrmann TRW, Ganzer R, Blana A, Burchardt M, Gross AJ (2009) Thulum:YAG vaporesection of the prostate. First results. Urologe 48:529–534
Bach T, Wendt-Nordahl G, Michel MS, Herrmann TRW, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27:541–545
Bach T, Herrmann TRW, Haecker A, Michel MS, Gross AJ (2009) Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 104:361–364
Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W, Zhang P, Wang XX (2009) Comparison of 2-μm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75:194–199
Bach T, Netsch C, Haecker A, Michel MS, Herrmann TRW, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39–43
Heinrich E, Wendt-Nordahl G, Honeck P, Alken P, Knoll T, Michel MS, Haecker A (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 24:75–79
Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, Reich O, Stief C, Vavassori I (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55(6):1345–1357
Conflict of interest statement
There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bach, T., Xia, S.J., Yang, Y. et al. Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?. World J Urol 28, 163–168 (2010). https://doi.org/10.1007/s00345-010-0522-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-010-0522-x